We are live on
!
Find out more
CC
Clearline Capital Portfolio holdings
AUM
$1.93B
1-Year Est. Return
38.13%
This Fund
S&P 500
This Quarter
Est. Return
-2%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$220M
AUM Growth
-$100M
(-31%)
Cap. Flow
-$91.5M
Cap. Flow
% of AUM
-41.52%
Top 10 Holdings %
Top 10 Hldgs %
57.02%
Holding
68
New
24
Increased
8
Reduced
12
Closed
23
Top Buys
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$13.2M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$10.4M |
| 3 |
Fossil Group
FOSL
|
+$7.55M |
| 4 |
Johnson Controls International
JCI
|
+$6.9M |
| 5 |
MYCC
ClubCorp Holdings, Inc.
MYCC
|
+$5.9M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$29.9M |
| 2 |
NCR Voyix
VYX
|
+$15.1M |
| 3 |
ODP
ODP
ODP
|
+$11.7M |
| 4 |
LGF
Lions Gate Entertainment
LGF
|
+$11.2M |
| 5 |
SAAS
inContact, Inc.
SAAS
|
+$10.1M |
Sector Composition
| 1 | Technology | 25.54% |
| 2 | Consumer Discretionary | 25.11% |
| 3 | Healthcare | 15.03% |
| 4 | Communication Services | 7% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Brookdale Senior Living
BKD
$3.65B
| $2.4M | 1.09% |
193,052
-668,411
| -78% | -$8.97M |
|
|
JUNO
27
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.19M | 0.99% |
+116,200
| New | +$2.84M |
|
28
CVS Health
CVS
$136B
| $2.09M | 0.95% |
+26,457
| New | +$2.14M |
|
29
Marathon Petroleum
MPC
$89.3B
| $1.73M | 0.79% |
+34,400
| New | +$1.56M |
|
|
P
30
DELISTED
Pandora Media Inc
P
| $1.48M | 0.67% |
+113,300
| New | +$1.4M |
|
31
Alphabet (Google) Class C
GOOG
$4.32T
| $1.38M | 0.62% |
+35,680
| New | +$1.39M |
|
32
Cognizant
CTSH
$21.1B
| $1.09M | 0.5% |
+19,475
| New | +$1.04M |
|
|
SYNT
33
DELISTED
Syntel Inc
SYNT
| $1.04M | 0.47% |
+52,502
| New | +$1.13M |
|
|
MIK
34
DELISTED
Michaels Stores, Inc
MIK
| $985K | 0.45% |
+48,180
| New | +$1.12M |
|
35
Immersion
IMMR
$218M
| $810K | 0.37% |
76,170
-338,710
| -82% | -$3.19M |
|
36
Myriad Genetics
MYGN
$585M
| $689K | 0.31% |
+41,334
| New | +$748K |
|
37
TripAdvisor
TRIP
$1.73B
| $677K | 0.31% |
+14,600
| New | +$803K |
|
|
PNK
38
DELISTED
Pinnacle Entertainment Inc.
PNK
| $676K | 0.31% |
+46,635
| New | +$623K |
|
39
PENN Entertainment
PENN
$2.85B
| $657K | 0.3% |
+47,637
| New | +$649K |
|
|
HZNP
40
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $566K | 0.26% |
+35,000
| New | +$635K |
|
|
FRSH
41
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $312K | 0.14% |
73,832
+200
| +0.3% | +$1.01K |
|
|
TVPT
42
DELISTED
Travelport Worldwide Limited
TVPT
| $303K | 0.14% |
21,500
-37,849
| -64% | -$527K |
|
43
TherapeuticsMD
TXMD
$23.6M
| $270K | 0.12% |
+935
| New | +$290K |
|
44
Adeia
ADEA
$2.86B
| – | – |
-575,244
| Closed | -$5.85M |
|
|
ASRT
45
DELISTED
Assertio
ASRT
| – | – |
-2,061
| Closed | -$3.09M |
|
46
Bristol-Myers Squibb
BMY
$124B
| – | – |
-56,932
| Closed | -$3.07M |
|
47
Designer Brands
DBI
$300M
| – | – |
-174,253
| Closed | -$3.57M |
|
48
DigitalBridge
DBRG
$2.92B
| – | – |
-92,680
| Closed | -$4.79M |
|
49
Dine Brands
DIN
$461M
| – | – |
-27,872
| Closed | -$2.21M |
|
50
Elevance Health
ELV
$80.9B
| – | – |
-13,248
| Closed | -$1.66M |
|
Similar funds
DCM
IHL
HC
RCAG
AF
QOP
HCL
6CM
Clearline Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Clearline Capital held 68 positions worth $220M, down 31% from $321M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Clearline Capital withdrew a net $91.5M in Q4 2016, closing 23 positions and reducing 12 holdings. Its most notable exit was ODP, an estimated $11.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Clearline Capital opened a new position in Fossil Group worth $6.49M.
- Clearline Capital's largest Q4 2016 buy was Fossil Group: 251,085 shares worth $6.49M.
- Clearline Capital added most to Envision Healthcare Holdings Inc in Q4 2016, an estimated $13.2M increase.
- Clearline Capital's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $29.9M.
- Clearline Capital fully exited ODP in Q4 2016, selling an estimated $11.7M.
- Clearline Capital's ten largest holdings make up 57% of its $220M portfolio in Q4 2016.
- Clearline Capital opened 24 new positions and closed 23 in Q4 2016.
- Clearline Capital's portfolio value fell 31% quarter-over-quarter to $220M.
Based on Clearline Capital's 13F filing for Q4 2016, filed 14 Feb 2017.